Medical devices partnership

EVEON and Laboratoires Théa have announced a partnership that will assist both companies in the development of innovative medical devices.

Medical devices partnership
Colin Kerr
Colin Kerr
Published: Monday, February 1, 2021
EVEON and Laboratoires Théa have announced a partnership that will assist both companies in the development of innovative medical devices. “We are delighted to be able to join forces with EVEON. This partnership is part of our continued commitment in favour of innovative solutions for the care of eye disorders. Connected medical devices are a revolution that must be made available to eyecare professionals for the greater benefit of their patients,” said Jean-Frédéric Chibret, President of Laboratoires Théa. “This joint endeavour with Théa Open Innovation is a pledge of confidence and commitment. We are proud to contribute together to the development of new-generation devices that respond to the challenges of modern medicine, which seeks to become more personalised, more responsive to each patient’s needs,” said Vincent Tempelaere, CEO of EVEON. www.eveon.eu www.laboratoires-thea.com
Tags: eveon thea partnership
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...